MAPP BIOPHARMACEUTICAL, INC.

US UEI M9V9QTHR1H28 · SME

30public awards

$28.0Mtotal public funding

2026-07-02latest award

State aid awards (30)

Date	Amount	Type	Programme	Granted by
2026-07-02	$295k	Grant	ALLERGY AND INFECTIOUS DISEASES RESEARCH	Department of Health and Human Services
2025-09-24	$993k	Grant	Development of highly potent human monoclonal for RSV immunoprophylaxi	Department of Health and Human Services
2025-06-09	$295k	Grant	A Novel Cost-Effective Multispecific Therapeutic for Dengue	Department of Health and Human Services
2020-07-28	$999k	Grant	Marburg Virus Prophylactic Medical Countermeasure	Department of Defense
2020-07-02	$2.7M	Grant	Development of highly potent human monoclonal for RSV immuno-prophylax	Department of Health and Human Services
2018-09-27	$150k	Grant	Marburg Virus Prophylactic Medical Countermeasure	Department of Defense
2018-06-29	$298k	Grant	Post-exposure immunotherapy for ricin exposure	Department of Health and Human Services
2018-01-15	$600k	Grant	Development of highly potent human monoclonals for RSV immunoprophylax	Department of Health and Human Services
2017-09-01	$225k	Grant	Direct Sequencing of Antibodies of the Influenza Immune Response	Department of Health and Human Services
2017-07-01	$3.0M	Grant	MR191_An Immunoprotectantfor Marburg Virus	Department of Health and Human Services
2017-06-22	$1,000k	Grant	Ricin Toxin Protective Monoclonal Antibodies with Improved Serum Half-	Department of Defense
2017-02-01	$255k	Grant	Direct sequencing of serum antibodies after infection	Department of Health and Human Services
2016-08-01	$240k	Grant	Rapid Response Agents Against Filovirus Outbreaks Using Vectored Immun	Department of Health and Human Services
2015-01-05	$229k	Grant	Pseudomonas antibodies with designed glycans	Department of Health and Human Services
2014-12-11	$150k	Grant	Ricin Toxin Protective Monoclonal Antibodies with Improved Serum Half-	Department of Defense
2014-08-20	$2.3M	Grant	An SEB Immunoprotectant	Department of Health and Human Services
2014-07-01	$600k	Grant	A human monoclonal for RSV prophylaxis	Department of Health and Human Services
2014-07-01	$3.0M	Grant	An Immunoprotectant for Marburg Virus	Department of Health and Human Services
2014-01-01	$225k	Grant	Novel Immunotherapy for Brain Cancer	Department of Health and Human Services
2012-01-01	$300k	Grant	A Monoclonal Cocktail for CDI	Department of Health and Human Services
2011-01-01	$3.0M	Grant	A Monoclonal Antibody Immunoprotectant for Ebola Virus	Department of Health and Human Services
2010-01-01	$600k	Grant	Development of a monoclonal immunoprotectant for ricin	Department of Health and Human Services
2009-01-01	$525k	Grant	An Immunoprotectant for Marburg Virus	Department of Health and Human Services
2008-01-01	$600k	Grant	Monoclonal Antibody SEB Immunoprotectant	Department of Health and Human Services
2008-01-01	$2.8M	Grant	Monoclonal Antibodies for Alzheimer's Immunotherapy	Department of Health and Human Services
2007-01-01	$997k	Grant	Development of a C. difficile Monoclonal-based Product	Department of Health and Human Services
2007-01-01	$271k	Grant	A Monoclonal Antibody Immunoprotectant for Ebola Virus	Department of Health and Human Services
2006-01-01	$571k	Grant	A HUMAN MONOCLONAL COCKTAIL FOR RSV IMMUNOTHERAPY	Department of Health and Human Services
2005-01-01	$446k	Grant	MONOCLONAL ANTIBODIES FOR ALZHEIMER'S IMMUNOTHERAPY	Department of Health and Human Services
2004-01-01	$300k	Grant	ANTI-C. DIFFICILE HUMAN MONOCLONALS FOR IMMUNOTHERAPY	Department of Health and Human Services